These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 21264255)

  • 1. The antiviral spectra of TRIM5α orthologues and human TRIM family proteins against lentiviral production.
    Ohmine S; Sakuma R; Sakuma T; Thatava T; Takeuchi H; Ikeda Y
    PLoS One; 2011 Jan; 6(1):e16121. PubMed ID: 21264255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants for the rhesus monkey TRIM5alpha-mediated block of the late phase of HIV-1 replication.
    Sakuma R; Ohmine S; Ikeda Y
    J Biol Chem; 2010 Feb; 285(6):3784-3793. PubMed ID: 19951947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of TRIM5α RING domain E3 ubiquitin ligase activity in capsid disassembly, reverse transcription blockade, and restriction of simian immunodeficiency virus.
    Kim J; Tipper C; Sodroski J
    J Virol; 2011 Aug; 85(16):8116-32. PubMed ID: 21680520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The V86M mutation in HIV-1 capsid confers resistance to TRIM5α by abrogation of cyclophilin A-dependent restriction and enhancement of viral nuclear import.
    Veillette M; Bichel K; Pawlica P; Freund SM; Plourde MB; Pham QT; Reyes-Moreno C; James LC; Berthoux L
    Retrovirology; 2013 Feb; 10():25. PubMed ID: 23448277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rhesus monkey TRIM5alpha restricts HIV-1 production through rapid degradation of viral Gag polyproteins.
    Sakuma R; Noser JA; Ohmine S; Ikeda Y
    Nat Med; 2007 May; 13(5):631-5. PubMed ID: 17435772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unique features of TRIM5alpha among closely related human TRIM family members.
    Li X; Gold B; O'hUigin C; Diaz-Griffero F; Song B; Si Z; Li Y; Yuan W; Stremlau M; Mische C; Javanbakht H; Scally M; Winkler C; Dean M; Sodroski J
    Virology; 2007 Apr; 360(2):419-33. PubMed ID: 17156811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Species-specific variation in the B30.2(SPRY) domain of TRIM5alpha determines the potency of human immunodeficiency virus restriction.
    Stremlau M; Perron M; Welikala S; Sodroski J
    J Virol; 2005 Mar; 79(5):3139-45. PubMed ID: 15709033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation of an active Lv1 gene from cattle indicates that tripartite motif protein-mediated innate immunity to retroviral infection is widespread among mammals.
    Ylinen LM; Keckesova Z; Webb BL; Gifford RJ; Smith TP; Towers GJ
    J Virol; 2006 Aug; 80(15):7332-8. PubMed ID: 16840314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional replacement of the RING, B-box 2, and coiled-coil domains of tripartite motif 5alpha (TRIM5alpha) by heterologous TRIM domains.
    Li X; Li Y; Stremlau M; Yuan W; Song B; Perron M; Sodroski J
    J Virol; 2006 Jul; 80(13):6198-206. PubMed ID: 16775307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclophilin A renders human immunodeficiency virus type 1 sensitive to Old World monkey but not human TRIM5 alpha antiviral activity.
    Keckesova Z; Ylinen LM; Towers GJ
    J Virol; 2006 May; 80(10):4683-90. PubMed ID: 16641261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. All three variable regions of the TRIM5alpha B30.2 domain can contribute to the specificity of retrovirus restriction.
    Ohkura S; Yap MW; Sheldon T; Stoye JP
    J Virol; 2006 Sep; 80(17):8554-65. PubMed ID: 16912305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lentiviral gene therapy against human immunodeficiency virus type 1, using a novel human TRIM21-cyclophilin A restriction factor.
    Chan E; Schaller T; Eddaoudi A; Zhan H; Tan CP; Jacobsen M; Thrasher AJ; Towers GJ; Qasim W
    Hum Gene Ther; 2012 Nov; 23(11):1176-85. PubMed ID: 22909012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRIM5α and Species Tropism of HIV/SIV.
    Nakayama EE; Shioda T
    Front Microbiol; 2012; 3():13. PubMed ID: 22291694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruption of human TRIM5alpha antiviral activity by nonhuman primate orthologues.
    Berthoux L; Sebastian S; Sayah DM; Luban J
    J Virol; 2005 Jun; 79(12):7883-8. PubMed ID: 15919943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A specific region of 37 amino acid residues in the SPRY (B30.2) domain of African green monkey TRIM5alpha determines species-specific restriction of simian immunodeficiency virus SIVmac infection.
    Nakayama EE; Miyoshi H; Nagai Y; Shioda T
    J Virol; 2005 Jul; 79(14):8870-7. PubMed ID: 15994780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRIM5α and TRIM22 are differentially regulated according to HIV-1 infection phase and compartment.
    Singh R; Patel V; Mureithi MW; Naranbhai V; Ramsuran D; Tulsi S; Hiramen K; Werner L; Mlisana K; Altfeld M; Luban J; Kasprowicz V; Dheda K; Abdool Karim SS; Ndung'u T
    J Virol; 2014 Apr; 88(8):4291-303. PubMed ID: 24478420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primate TRIM34 is a broadly-acting, TRIM5-dependent lentiviral restriction factor.
    Twentyman J; Khalifeh A; Felton AL; Emerman M; OhAinle M
    bioRxiv; 2023 Mar; ():. PubMed ID: 36993223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteasome inhibition reveals that a functional preintegration complex intermediate can be generated during restriction by diverse TRIM5 proteins.
    Anderson JL; Campbell EM; Wu X; Vandegraaff N; Engelman A; Hope TJ
    J Virol; 2006 Oct; 80(19):9754-60. PubMed ID: 16973579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytoplasmic body component TRIM5{alpha} requires lipid-enriched microdomains for efficient HIV-1 restriction.
    Ohmine S; Sakuma R; Sakuma T; Thatava T; Solis GP; Ikeda Y
    J Biol Chem; 2010 Nov; 285(45):34508-17. PubMed ID: 20810659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclophilin A and TRIM5alpha independently regulate human immunodeficiency virus type 1 infectivity in human cells.
    Sokolskaja E; Berthoux L; Luban J
    J Virol; 2006 Mar; 80(6):2855-62. PubMed ID: 16501094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.